PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Support Care Cancer. Author manuscript; available in PMC Mar 15, 2010.
Published in final edited form as:
PMCID: PMC2838893
NIHMSID: NIHMS85898
“What concerns me is…” Expression of emotion by advanced cancer patients during outpatient visits
Wendy G. Anderson, Stewart C. Alexander, Keri L. Rodriguez, Amy S. Jeffreys, Maren K. Olsen, Kathryn I. Pollak, James A. Tulsky, and Robert M. Arnold
Wendy G. Anderson, Department of Medicine, Division of Hospital Medicine and Palliative Care Program, University of California, San Francisco, 521 Parnassus Avenue, Suite C-126, Box 0903, San Francisco, CA 94143-0903, USA;
anderson.wg/at/gmail.com
Objective
Cancer patients have high levels of distress, yet oncologists often do not recognize patients’ concerns. We sought to describe how patients with advanced cancer verbally express negative emotion to their oncologists.
Materials and methods
As part of the Studying Communication in Oncologist–Patient Encounters Trial, we audio-recorded 415 visits that 281 patients with advanced cancer made to their oncologists at three US cancer centers. Using qualitative methodology, we coded for verbal expressions of negative emotion, identified words patients used to express emotion, and categorized emotions by type and content.
Results
Patients verbally expressed negative emotion in 17% of the visits. The most commonly used words were: “concern,” “scared,” “worried,” “depressed,” and “nervous.” Types of emotion expressed were: anxiety (46%), fear (25%), depression (12%), anger (9%), and other (8%). Topics about which emotion was expressed were: symptoms and functional concerns (66%), medical diagnoses and treatments (54%), social issues (14%), and the health care system (9%). Although all patients had terminal cancer, they expressed negative emotion overtly related to death and dying only 2% of the time.
Conclusions
Patients infrequently expressed negative emotion to their oncologists. When they did, they typically expressed anxiety and fear, indicating concern about the future. When patients use emotionally expressive words such as those we described, oncologists should respond empathically, allowing patients to express their distress and concerns more fully.
Keywords: Patients, Cancer, Emotion, Distress, Communication
Psychological distress, particularly in the form of anxiety and depression, is common in cancer patients, with a reported prevalence between 30 and 50% [13, 24, 27, 53, 54, 60]. Psychological distress has been correlated with lower quality of life [3, 4, 54 ,58], a desire to hasten death [5], and caregiver distress [30, 50, 57], as well as increased health-care utilization [15, 22, 33] and shorter survival [19, 35, 52]. Cancer patients with unresolved concerns are more distressed than those whose concerns are resolved [7, 18, 26, 38]. The way oncologists communicate impacts patients’ disclosure of concerns and their distress associated with such concerns. When clinicians acknowledge patients’ emotions and invite discussion, they give them the opportunity to convey their concerns. Patients whose physicians are empathic and invite discussion disclose more concerns [36] and, as a result, have lower levels of distress [20, 45, 49].
Unfortunately, multiple studies document that oncologists, like other medical providers, usually do not respond empathically when patients express emotion [6, 34, 56]. For example, a cancer patient may state, “I’m worried about these headaches.” The oncologist can respond empathically by acknowledging the emotion: “I can understand how they would be difficult—can you tell me more?” Acknowledging the emotion allows the patient to talk further about the concern associated with the emotion: “I am afraid the cancer is coming back”. A bio-medically focused response ignores the emotion: “Do you feel nauseated with the headaches?” While this response provides the clinician with medical information, it does not elicit information about the patient’s concerns.
To respond empathically to patient distress, oncologists must first recognize it. However, oncologists’ recognition of patient distress is often poor [16, 21, 37, 39, 51]. This may explain why oncologists do not offer empathic responses as often as may be desired. Patients express emotion in a variety of ways—through words, tone of voice, facial expressions, and body language [46]. Of these methods, direct verbal expression, where patients name the emotion they are experiencing, is not only the most overt and thus easiest to recognize, but also the most highly correlated with self-reported distress [12, 48].
We sought to describe how oncology outpatients verbally express distress to their oncologists. In the Studying Communication in Oncologist–Patient Encounters Trial (SCOPE), we audio-recorded 415 visits between 59 oncologists and 281 patients with advanced cancer [28]. We identified all instances where patients verbally expressed negative emotion in these visits, recorded the words they used to express emotion, and classified these expressions by type and topic. We offer this analysis as a guide for clinicians to identify distress in their own patients.
Participants
Outpatient visits between patients with advanced cancer and their oncologists were audio-recorded at three cancer centers in the USA: Duke University, the Durham Veterans Affairs Medical Center, and the University of Pittsburgh. Details about recruitment are described elsewhere [28]. Briefly, medical, gynecological, and radiation oncologists were recruited and enrolled into the study and then asked to identify patients who they “would not be surprised if they died or were admitted to an intensive-care unit within the next year.”
Measures
Digital recorders were placed unobtrusively in the clinic exam rooms before the oncologists entered. Each recorded visit was coded for the presence of verbal expression of negative emotion by the patient. We focused on negative, as opposed to positive or neutral, emotions because we were interested in describing the expression of distress. For each expression of emotion, we recorded the word the patient used to express the emotion and coded the type of emotion that was expressed and the topic about which the emotion was expressed. Sociodemographic information was collected from patients and oncologists at study enrollment.
Analysis
To reliably identify instances of negative emotional expression and code each by type and topic, we developed a standardized, explicit coding process [10, 11]. Based on previous work [6, 34, 56], we defined negative emotional expression as any instance where a patient used words to describe a negative emotional state in the past, present, or future; for example, “I’m anxious about this test” or “I was feeling depressed.” We identified all instances of verbal expression of negative emotion using a web-based coding software (ENCOUNTER) that allowed direct coding on the audio files. To establish intercoder reliability for identification of expressions of emotion, two coders independently coded a random 20% of the recordings; Cohen’s kappa for agreement between coders was 0.65, indicating substantial agreement [9, 31].
We then transcribed all coded utterances, identified the specific word(s) that expressed the emotion, and described the topic about which the emotion was expressed. To verify the reliability of this process, 20% of the sample was double-coded at this stage [40]. The two coders identified the same emotionally expressive word(s) in 22 (92%) instances, completely agreed on the topic of the emotion in 20 (83%) instances, and agreed at least partially for 22 (92%).
Our categories for type of emotion were based on the primary negative emotions as defined in the psychology literature: anxiety, fear, anger, and depression or sadness [47, 55]. We grouped patients’ emotional expressions into these categories using dictionary and thesaurus definitions to determine to which category the words related linguistically [1, 2]. Emotions not related to one of the primary categories were classified as other. Codes were mutually exclusive, so each utterance could only be coded as one type of emotion.
To create categories that described the topics about which patients expressed emotion in a clinically relevant way, we used an iterative process [10, 11]. First, two coders independently examined the transcribed utterances and topic descriptions of the expressions of emotion to identify common themes. A preliminary coding scheme was developed using these themes and informed by categorizations used in previous studies [6, 14] and used by both coders to independently code all of the utterances. The two coders then met to review their coding, resolve disagreements, and further modify and refine the codebook. Often, the topic of emotional expression related to more than one category; thus, the topic codes were not mutually exclusive.
Finally, to provide a deeper understanding of patients’ expressions of emotion, we conducted a thematic analysis of the transcribed utterances and topic descriptions using open- and axial-coding techniques [10, 11]. During open coding, two coders independently identified attributes pertinent to the topic of emotional expression. Coders then compared attributes and achieved consensus by developing decision rules to reliably classify attributes. In axial coding, the attributes were grouped into overarching themes using decision rules, and the relationship between themes was described. A third coder reviewed the coding scheme and verified the accuracy of coding.
Participants
We analyzed 415 visits of 281 patients with 59 oncologists (1–2 visits per patient, 1–9 visits per oncologist). Patient sociodemographic and clinical characteristics are listed in Table 1. The patients’ mean age was 60 years (SD=13); 49% were men. Approximately 83% of the patients were white, 15% African American, and 1.4% Hispanic. Approximately 28% of the patients had been diagnosed with a hematological malignancy, 16% had lung cancer, 15% had breast cancer, 12% had a gastrointestinal malignancy, 10% had a brain malignancy, and 19% were classified as other, including gynecologic, prostate, and head and neck cancers. About 79% of patients had seen their oncologist for at least three previous visits.
Table 1
Table 1
Patient and oncologist demographics
Frequency of verbal expression of negative emotion
We identified 114 instances where patients verbally expressed negative emotion in 72 (17%) of the 415 recorded conversations. Approximately 64 (23%) of the 281 recorded patients expressed an emotion during at least one of the visits with their oncologist.
Words used to express emotion and types of negative emotions expressed
The most common words used to express emotion were “concern” and “scared” (17 instances each), followed by “worried” (16 instances), “depressed” (11 instances), and “nervous” (10 instances; Table 2 shows all the words used to express emotion and the frequency of their use). The words patients used to express emotion most commonly related to the primary emotions of anxiety (46% of instances) and fear (25%), whereas depression (12%) and anger (9%) were less common (Table 2 shows how all the words were grouped into the emotion categories). Examples of each type of emotion are shown below:
Anxiety: “You see I had to wait so long—and that is just nerve racking.
Fear: “It’s not bone cancer is it? You’re scaring me.”
Depression: “Because that’s so depressing” (Discussing her hair loss).
Anger: “It aggravates me—I used to do everything outside.”
Table 2
Table 2
Coding scheme for type of emotion, results of coding, and examples
Eight percent of emotions did not fit into one of these categories and were classified as other.
Topics about which patients expressed emotion
We defined five categories for the topic of emotion (Table 3). Patients most commonly expressed emotion about symptoms and functional issues (66% of instances), including physical symptoms, mental symptoms, and functional concerns, for example:
“I get like a panic attack.”
“I can’t walk at all…When she said are you worried about your health?—Yes, every time I come to a curb or a step.”
Table 3
Table 3
Coding scheme for topic of emotion, results of coding, and examples
In most instances of emotional expression about symptoms, patients did not describe the reason for their concern. When patients did describe the cause of their concern, it was that the symptom indicated cancer progression. For example, one woman said about her pain, “When it aches, I get concerned…I worry that it’s the cancer.”
Medical diagnoses and treatments were also frequently a topic of emotion (54% of instances), including cancer and noncancer illness diagnoses and treatments, tests and test results, and medications and medication side effects.
“You mentioned the PET scan—and you scared me.
” “I’m sorta scared about that medicine for the bowel cancer.”
Social issues, including reference to family, finances, and the presence or lack of social support, were a topic of emotion in 14% of instances:
“So I’m kinda concerned about that” (If cannot start back at work, she may lose her job).
The health care system, including comments about communication and quality of care, was the topic of 9% of instances:
“I think it’s stress” (Stressed because patient was told over the phone that tumor markers were up).
Overt discussion of death and dying, where patients overtly discussed their mortality, was only found in 2% of the expressions of emotion. In expressions of emotion where patients did overtly discussed death and dying, they described dying from cancer progression. For example, one woman said she was depressed because she knew “the disease will get me in the end.”
We analyzed 415 recorded visits between 281 patients with advanced cancer and their oncologists and found that patients verbally expressed an emotion in 17% of the visits. Anxiety and fear were the most common emotions expressed. The most common topics of emotion were symptoms and function and medical issues. Social issues, the health care system (e.g., communication and quality of care), and death and dying were less frequently topics of emotion.
In our study, the rate of expression of emotion seems lower than in other studies of cancer, primary care, and surgical patients [6, 34]. We feel this difference is due not to differential rates of emotional expression but to differences in methodology. First, in past studies of physician’s responses to “cues” or “clues” that patients give during clinical visits, emotional as well as informational and social statements were included [6, 34]. Thus, the rates of patient cues per visit were higher compared with our study, where we solely included emotional statements. Second, because we were interested in the expression of distress, we coded only the expression of negative emotions, whereas other studies coded both positive and negative emotions [6, 34, 56]. Third, in our analysis, we only included “direct” expressions of emotion, when patients state a word that describes the emotion they are experiencing. Other studies have also included “indirect” expressions of emotion, where patients allude to the presence of an emotion but do not name it directly [6, 34, 56]. We did not include these expressions in our analysis because we could not reliably code the type of emotion being expressed indirectly.
Still, the fact that only 17% of visits in our study contained a direct expression of distress is concerning, given the high rates of reported distress in cancer patients [13, 24, 27, 53, 54, 60]. Patients may not discuss emotional issues because they do not feel it is their oncologists’ role to address them [48]. Physician behaviors also influence patients’ disclosure of concerns and distress. When physicians focus on psychosocial aspects of care, use open-ended questions, listen actively, and make empathic statements, their patients are more likely to express distress and concerns [36, 48]. An analysis of the oncologists’ behaviors in the recordings used in this study is reported elsewhere; in that analysis, oncologists responded empathically to patients’ expressions of emotion less than one third of the time [42]. Research shows that when clinicians repeatedly miss patients’ expressions of emotion, patients eventually cease to express emotion [56]. As the majority of the patients in our recorded conversations knew their oncologist, it may be that the patients “learned” not to express emotion by the time they were recorded. This underscores the importance of recognizing and responding empathically to patient expressions of emotion.
The words patients used to express emotion, such as “concern,” “scared,” “worried,” “depressed,” and “nervous” are all commonly used in spoken English [32]. However, that these words contain an emotional content is not obvious unless the listener is primed to see them as emotionally charged. We hope that oncologists can use these words as flags marking opportunities to explore patients’ concerns. Unlike nonverbal expressions of emotion, which can be hard for the untrained observer to recognize [12], verbal expressions of emotion are more straightforward and recognizable.
The types of emotion patients expressed and the topics about which they expressed emotion give us a sense of the concerns patients chose to discuss with their oncologists. In our study, the predominant emotions expressed were anxiety and fear, indicating that patients were concerned about the future and uncertainty (e.g., prognosis). Whereas the negative emotions anger and depression are related to a current, known negative event, anxiety and fear are related to the possibility or threat of a negative event [47, 55]. Although the topic of emotion was most often symptoms, function, or medical issues, the root of patients’ concern about these issues was often their meaning: “Does a headache mean the cancer is in my brain?” “Can we still control my cancer if they are taking my chemotherapy drug off the market?” These concerns indicate that oncologists providing information, when possible, will help to decrease uncertainty. Responding to emotion empathically is still important because the information may be bad news. Even if the oncologist cannot solve the patients’ concern with information, encouraging patients to discuss concerns can still decrease distress [20, 45, 49].
Another important finding was that certain topics were relatively infrequent topics of emotional expression. Specifically, patients infrequently expressed negative emotions about social issues, the health care system (e.g., communication and quality of care), and death and dying (14, 9, and 2% of instances, respectively). Our results could mean that patients were not concerned about these topics or that they were concerned but did not express that concern to their oncologist. Previous studies have documented that patients express different concerns to different types of doctors. For example, Levinson et al. [34] found that patients were more likely to express feelings about their biomedical condition in surgical outpatient visits and were more likely to express emotion about psychological or social concerns in primary-care visits. Thus, it may be that the patients in our study perceived their oncologist’s role as relating more to their biomedical condition—symptoms and medical issues— than their social or psychological concerns.
The low frequency of expression of emotion about the health care system—issues of quality of care and communication—is interesting, given that these areas have been a focus of research [17, 28]. Although objective studies of oncologists communication suggest that they often do not meet literature-recommended standards [6, 34, 56], satisfaction with care and communication is usually high [23, 29]. This disconnect is worthy of further study.
The low frequency of emotional expression about end-of-life issues was surprising because all of the patients had terminal cancer. Other research has shown that most patients want their oncologists to be willing to talk about death and dying [25, 59] and cite emotional support as an important physician skill to help them cope when discussing the future [8]. Unfortunately, factors such as disease stage do not predict whether patients want to talk about end-of-life issues [41], so there is no reliable way to predict whether a given patient has concerns about death and dying. By responding empathically to expressions of emotion, physicians can let patients know they are willing to talk about difficult topics without forcing the discussion. In our study, emotional expression about death and dying seemed related to concerns about cancer progression, which in turn related to concerns about symptoms. It is possible that concerns about death and dying were the underlying reason for concern in patients’ frequent expressions of emotion about symptoms. Given the methodology of our study, we cannot know how many patients were concerned about death and dying. However, past studies indicate that patients who described their concerns about symptoms and medical issues narrowly might have given a fuller account if their oncologists had responded empathically to their expressions of emotion [36, 42].
Our study has several limitations. First, we only coded the verbal expression of emotion. Although verbal expressions of emotion are the easiest to detect, they are less sensitive than tone of voice and nonverbal expressions, such as facial expressions and body language [12, 48]. Second, we only coded negative emotions. We elected to code only negative emotions because we were interested in the detection of distress. Describing the effect of patients’ expression of and oncologists’ responses to positive emotions will be important in future work. Third, patients may have expressed emotion less frequently because their visit was recorded, resulting in a Hawthorne effect [44]. Although the literature indicates that recording does not typically alter behavior [43], this is a concern in any study involving recorded medical exchanges. Fourth, because we recorded visits at US academic medical centers, we may not be able to generalize our findings to other settings.
In summary, the patients in our study infrequently expressed emotion to their oncologists. When they did, they typically expressed anxiety and fear about symptoms, indicating concern about the future. Specific concerns about cancer progression and death and dying were left implicit by the patient and were not explored by the oncologists. We hope that oncologists can use the emotion words described in this paper as flags to identify expressions of emotion by their patients. Although oncologists cannot always solve the cause of patients’ concerns, inviting patients to express them more fully can reduce associated distress.
Acknowledgments
Funding: The National Cancer Institute, R01CA100387, supported the SCOPE project. The Open Society Institute and the Senator H. John Heinz III Fellowship in Palliative Medicine at the University of Pittsburgh’s Institute to Enhance Palliative Care funded Dr. Anderson’s salary.
Contributor Information
Wendy G. Anderson, Department of Medicine, Division of Hospital Medicine and Palliative Care Program, University of California, San Francisco, 521 Parnassus Avenue, Suite C-126, Box 0903, San Francisco, CA 94143-0903, USA.
Stewart C. Alexander, Department of Medicine, Duke University Medical Center, Erwin Road, Durham, NC 27710, USA; Center for Palliative Care, Duke University Medical Center, Hock Plaza, Suite 1105, 2424 Erwin Road, Box 2720, Durham, NC 27705-3860, USA; Center for Health Services Research, Durham VA Medical Center, 508 Fulton Street, Durham, NC 27705, USA.
Keri L. Rodriguez, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, MUH 933W, 200 Lothrop Street, Pittsburgh, PA 15213, USA; Institute for Doctor–Patient Communication, University of Pittsburgh School of Medicine, MUH 933W, 200 Lothrop Street, Pittsburgh, PA 15213, USA; Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, University Drive C (151C-U), Pittsburgh, PA 15240-1000, USA.
Amy S. Jeffreys, Center for Health Services Research, Durham VA Medical Center, 508 Fulton Street, Durham, NC 27705, USA.
Maren K. Olsen, Center for Health Services Research, Durham VA Medical Center, 508 Fulton Street, Durham, NC 27705, USA; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Erwin Road, Durham, NC 27710, USA.
Kathryn I. Pollak, Cancer Prevention, Detection and Control Research Program, Duke Comprehensive Cancer Center, 2424 Erwin Road, Hock, Plaza Suite 601, Durham, NC 27705, USA; Department of Community and Family Medicine, Duke University Medical Center, 318 Hanes House, DUMC 2914, Durham, NC 27710, USA.
James A. Tulsky, Department of Medicine, Duke University Medical Center, Erwin Road, Durham, NC 27710, USA; Center for Palliative Care, Duke University Medical Center, Hock Plaza, Suite 1105, 2424 Erwin Road, Box 2720, Durham, NC 27705-3860, USA; Center for Health Services Research, Durham VA Medical Center, 508 Fulton Street, Durham, NC 27705, USA; Cancer Prevention, Detection and Control Research Program, Duke Comprehensive Cancer Center, 2424 Erwin Road, Hock, Plaza Suite 601, Durham, NC 27705, USA.
Robert M. Arnold, Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, MUH 933W, 200 Lothrop Street, Pittsburgh, PA 15213, USA; Institute for Doctor–Patient Communication, University of Pittsburgh School of Medicine, MUH 933W, 200 Lothrop Street, Pittsburgh, PA 15213, USA; Institute to Enhance Palliative Care, University of Pittsburgh School of Medicine, MUH 933W, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
1. Dictionary.com Unabridged (v 1.1) from Dictionary.com website: http://dictionary.reference.com.
2. Roget’s New Millennium™ Thesaurus. First Edition (v 1.3.1) from Thesaurus.com website: http://thesaurus.reference.com.
3. Badger TA, Braden CJ, Mishel MH. Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer. Oncol Nurs Forum. 2001;28:567–574. [PubMed]
4. Badger TA, Braden CJ, Mishel MH, Longman A. Depression burden, psychological adjustment, and quality of life in women with breast cancer: patterns over time. Res Nurs Health. 2004;27:19–28. [PubMed]
5. Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M, Nelson CJ, Brescia R. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000;284:2907–2911. [PubMed]
6. Butow PN, Brown RF, Cogar S, Tattersall MH, Dunn SM. Oncologists’ reactions to cancer patients’ verbal cues. Psychooncology. 2002;11:47–58. [PubMed]
7. Chaturvedi SK, Shenoy A, Prasad KM, Senthilnathan SM, Premlatha BS. Concerns, coping and quality of life in head and neck cancer patients. Support Care Cancer. 1996;4:186–190. [PubMed]
8. Clayton JM, Butow PN, Arnold RM, Tattersall MH. Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers. Cancer. 2005;103:1965–1975. [PubMed]
9. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.
10. Corbin J, Strauss A. Basics of qualitative research: grounded theory, procedures and techniques. Sage; Thousand Oaks, CA: 1990.
11. Crabtree BF, Miller W. Doing qualitative research. Sage; Newbury Park, CA: 1992.
12. Davenport S, Goldberg D, Millar T. How psychiatric disorders are missed during medical consultations. Lancet. 1987;2:439–441. [PubMed]
13. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL., Jr The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751–757. [PubMed]
14. Detmar SB, Muller MJ, Wever LD, Schornagel JH, Aaronson NK. The patient–physician relationship. Patient–physician communication during outpatient palliative treatment visits: an observational study. JAMA. 2001;285:1351–1357. [PubMed]
15. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107. [PubMed]
16. Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001;84:1011–1015. [PMC free article] [PubMed]
17. Fallowfield L, Jenkins V, Farewell V, Saul J, Duffy A, Eves R. Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial. Lancet. 2002;359:650–656. [PubMed]
18. Farrell C, Heaven C, Beaver K, Maguire P. Identifying the concerns of women undergoing chemotherapy. Patient Educ Couns. 2005;56:72–77. [PubMed]
19. Fawzy FI, Fawzy NW, Hyun CS, Elashoff R, Guthrie D, Fahey JL, Morton DL. Malignant melanoma. Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry. 1993;50:681–689. [PubMed]
20. Fogarty LA, Curbow BA, Wingard JR, McDonnell K, Somerfield MR. Can 40 seconds of compassion reduce patient anxiety? J Clin Oncol. 1999;17:371–379. [PubMed]
21. Ford S, Fallowfield L, Lewis S. Can oncologists detect distress in their out-patients and how satisfied are they with their performance during bad news consultations? Br J Cancer. 1994;70:767–770. [PMC free article] [PubMed]
22. Fulop G, Strain JJ, Vita J, Lyons JS, Hammer JS. Impact of psychiatric comorbidity on length of hospital stay for medical/surgical patients: a preliminary report. Am J Psychiatry. 1987;144:878–882. [PubMed]
23. George LK. Research design in end-of-life research: state of science. Gerontologist. 2002;42(3):86–98. [PubMed]
24. Grabsch B, Clarke DM, Love A, McKenzie DP, Snyder RD, Bloch S, Smith G, Kissane DW. Psychological morbidity and quality of life in women with advanced breast cancer: a cross-sectional survey. Palliat Support Care. 2006;4:47–56. [PubMed]
25. Hagerty RG, Butow PN, Ellis PA, Lobb EA, Pendlebury S, Leighl N, Goldstein D, Lo SK, Tattersall MH. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004;22:1721–1730. [PubMed]
26. Heaven CM, Maguire P. The relationship between patients’ concerns and psychological distress in a hospice setting. Psychooncology. 1998;7:502–507. [PubMed]
27. Kissane DW, Clarke DM, Ikin J, Bloch S, Smith GC, Vitetta L, McKenzie DP. Psychological morbidity and quality of life in Australian women with early-stage breast cancer: a cross-sectional survey. Med J Aust. 1998;169:192–196. [PubMed]
28. Koropchak CM, Pollak KI, Arnold RM, Alexander SC, Skinner CS, Olsen MK, Jeffreys AS, Rodriguez KL, Abernethy AP, Tulsky JA. Studying communication in oncologist patient encounters: The SCOPE Trial. Palliat Med. 2006;20:813–819. [PubMed]
29. Kristjanson LJ. Validity and reliability testing of the FAMCARE Scale: measuring family satisfaction with advanced cancer care. Soc Sci Med. 1993;36:693–701. [PubMed]
30. Kurtz ME, Kurtz JC, Given CW, Given B. Relationship of caregiver reactions and depression to cancer patients’ symptoms, functional states and depression—a longitudinal view. Soc Sci Med. 1995;40:837–846. [PubMed]
31. Landis R, Koch G. An Application of Hierarchical Kappa-type Statistics in the Assessment of Majority Agreement among Multiple Observers. Biometrics. 1977;33:363–374. [PubMed]
32. Leech G, Rayson P, Wilson A. Word frequencies in written and spoken English: based on the British National Corpus. Longman; London: 2001.
33. Levenson JL, Hamer RM, Rossiter LF. Relation of psychopathology in general medical inpatients to use and cost of services. Am J Psychiatry. 1990;147:1498–1503. [PubMed]
34. Levinson W, Gorawara-Bhat R, Lamb J. A study of patient clues and physician responses in primary care and surgical settings. JAMA. 2000;284:1021–1027. [PubMed]
35. Loberiza FR, Jr, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC, Lee SJ. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol. 2002;20:2118–2126. [PubMed]
36. Maguire P, Faulkner A, Booth K, Elliott C, Hillier V. Helping cancer patients disclose their concerns. Eur J Cancer. 1996;32A:78–81. [PubMed]
37. Merckaert I, Libert Y, Delvaux N, Marchal S, Boniver J, Etienne AM, Klastersky J, Reynaert C, Scalliet P, Slachmuylder JL, Razavi D. Factors that influence physicians’ detection of distress in patients with cancer: can a communication skills training program improve physicians’ detection? Cancer. 2005;104:411–421. [PubMed]
38. Parle M, Jones B, Maguire P. Maladaptive coping and affective disorders among cancer patients. Psychol Med. 1996;26:735–744. [PubMed]
39. Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S. Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol. 1998;16:1594–1600. [PubMed]
40. Patton M. Enhancing the quality and credibility of qualitative analysis. Health Serv Res. 1999;34:1189–1208. [PMC free article] [PubMed]
41. Pfeifer MP, Mitchell CK, Chamberlain L. The value of disease severity in predicting patient readiness to address end-of-life issues. Arch Intern Med. 2003;163:609–612. [PubMed]
42. Pollak K, Arnold R, Jeffreys A, Alexander S, Olsen M, Abernethy A, Skinner C, Rodriguez K, Tulsky J. Oncologist communication about emotion during visits with advanced cancer patients. J Clin Oncol. 2007 (in press) [PubMed]
43. Pringle M, Stewart-Evans C. Does awareness of being video recorded affect doctors’ consultation behaviour? Br J Gen Pract. 1990;40:455–458. [PMC free article] [PubMed]
44. Roethlisberger FH, Dickson WJ. Management and the Worker. Harvard University Press; Cambridge, MA: 1939.
45. Roter DL, Hall JA, Kern DE, Barker LR, Cole KA, Roca RP. Improving physicians’ interviewing skills and reducing patients’ emotional distress. A randomized clinical trial. Arch Intern Med. 1995;155:1877–1884. [PubMed]
46. Roter DL, Frankel RM, Hall JA, Sluyter D. The expression of emotion through nonverbal behavior in medical visits. Mechanisms and outcomes. J Gen Intern Med. 2006;21(1):S28–S34. [PMC free article] [PubMed]
47. Russell JA. Measures of emotion. In: Plutchik R, Kellerman H, editors. Emotion, Theory, Research, and Experience vol 4: The Measurement of Emotions. Academic; New York: 1989.
48. Ryan H, Schofield P, Cockburn J, Butow P, Tattersall M, Turner J, Girgis A, Bandaranayake D, Bowman D. How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care (Engl) 2005;14:7–15. [PubMed]
49. Schofield PE, Butow PN, Thompson JF, Tattersall MH, Beeney LJ, Dunn SM. Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol. 2003;14:48–56. [PubMed]
50. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1995;52:850–856. [PubMed]
51. Sollner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, Maislinger S. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counseling? Br J Cancer. 2001;84:179–185. [PMC free article] [PubMed]
52. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989;2:888–891. [PubMed]
53. Spiegel D. Cancer and depression. Br J Psychiatry. 1996:109–116. [PubMed]
54. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002;20:3137–3148. [PubMed]
55. Strongman KT. The Psychology of Emotion: From Everyday Life to Theory. Wiley; Chichester, West Sussex, England: 2003.
56. Suchman AL, Markakis K, Beckman HB, Frankel R. A model of empathic communication in the medical interview. JAMA. 1997;277:678–682. [PubMed]
57. Valdimarsdottir U, Helgason AR, Furst CJ, Adolfsson J, Steineck G. The unrecognised cost of cancer patients’ unrelieved symptoms:a nationwide follow-up of their surviving partners. Br J Cancer. 2002;86:1540–1545. [PMC free article] [PubMed]
58. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262:914–919. [PubMed]
59. Wenrich MD, Curtis JR, Shannon SE, Carline JD, Ambrozy DM, Ramsey PG. Communicating with dying patients within the spectrum of medical care from terminal diagnosis to death. Arch Intern Med. 2001;161:868–874. [PubMed]
60. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19–28. [PubMed]